Together, our report proposes USP39 as a biomarker and oncogenic factor in ESCC, with a potential for targeting the USP39/mTOR2/Rictor axis as a therapeutic strategy. The gene discussed is RICTOR; the disease is esophageal squamous cell carcinoma.